@article{omarjee:hal-01680961,
TITLE = {The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?},
AUTHOR = {Omarjee, Loukman and Jaquinandi, Vincent and Mahe, Guillaume},
URL = {https://univ-rennes.hal.science/hal-01680961},
JOURNAL = {Journal of Translational Medicine},
PUBLISHER = {BioMed Central},
VOLUME = {15},
NUMBER = {1},
PAGES = {255},
YEAR = {2017},
MONTH = Dec, DOI = {10.1186/s12967-017-1334-1},
KEYWORDS = {Atherosclerosis ; Inflammation ; Major adverse cardiovascular events ; Morbi-mortality ; Nilotinib ; peripheral artery disease ; Spondyloarthritis ; Tyrosine kinase inhibitor ; Vascular toxicity},
HAL_ID = {hal-01680961},
HAL_VERSION = {v1},
}